drugset / Trial / NCT05970783

A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

NCT05970783 ↗

Phase 3 Recruiting 414 enrolled Beijing Konruns Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this phase III trial to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease

Timeline

Start
2022-11-08
Primary completion
2024-03-11
Completion
2025-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Jincaopian Tablets Traditional medicine (herbal / TCM) 0.2 g Oral

Indications